Compare SHOO & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHOO | HAE |
|---|---|---|
| Founded | 1990 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.9B |
| IPO Year | 1993 | 1991 |
| Metric | SHOO | HAE |
|---|---|---|
| Price | $36.53 | $57.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $42.75 | ★ $86.00 |
| AVG Volume (30 Days) | ★ 1.6M | 1.0M |
| Earning Date | 02-25-2026 | 02-05-2026 |
| Dividend Yield | ★ 2.35% | N/A |
| EPS Growth | N/A | ★ 43.84 |
| EPS | 0.78 | ★ 3.65 |
| Revenue | ★ $2,362,727,000.00 | $1,318,275,000.00 |
| Revenue This Year | $13.06 | N/A |
| Revenue Next Year | $12.67 | $5.86 |
| P/E Ratio | $45.72 | ★ $16.25 |
| Revenue Growth | ★ 6.41 | N/A |
| 52 Week Low | $19.05 | $47.32 |
| 52 Week High | $46.88 | $87.32 |
| Indicator | SHOO | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 33.10 | 16.29 |
| Support Level | $33.89 | $64.75 |
| Resistance Level | $46.88 | $67.63 |
| Average True Range (ATR) | 2.13 | 2.44 |
| MACD | -1.16 | -0.89 |
| Stochastic Oscillator | 20.63 | 3.90 |
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.